Market News
Smart Trading. Simplified.
The World's First $20 Trillion Drug?
One small biotech holds the key to a revolution in treating Alzheimer's. Jeff Bezos, Goldman Sachs & a Big Pharma giant have invested billions into this unknown biotech.
Our research shows that anyone who gets in by June 2, 2021 could turn every $1,000 into $1.1 million.
Early investors who get in by June 2, 2021, could turn every $1,000 into $1.1 million.
How Amazon Got Started
Today, people all over the world know Amazon (AMZN) as a multi-billion-dollar ecommerce company that continues to push the retail industry in new directions. Amazon does much more than sell items through its website. It generates tremendous revenues through cloud computing services, movie production, and streaming services. Amazon also owns several smaller companies, including Whole […]
Jeff Bezos' Next Big Thing
The tech visionary who built a revolutionary $1.6 trillion company from scratch is quietly pouring his riches into a secretive project that could mean the end of Alzheimer's.
Early investors who get in by June 2, 2021, could turn every $1,000 into $1.1 million.
What Stocks Are Marginable?
Timing is everything when it comes to buying and selling stocks – particularly when you are only holding positions for days or weeks at a time. If you don’t make your move at exactly the right moment, the best-case scenario is missing out on profits. In the worst-case scenario, you wait just a bit too […]
Clean Energy Stocks: Rare Metal Discovery & How to Profit in 2021
Investors are preparing for a massive profit windfall come January as the incoming administration sets its $1.7 Trillion Clean Energy Plan in motion. Many clean energy stocks will double in 2021. Yet, this tiny niche is set to deliver gains as high as 2,400%.
Is EverQuote Stock A Buy?
EverQuote serves as a lead generator site and insurance marketplace for large insurance companies. Even though the activity on the website sounds a bit spammy, the insurance platform is accredited by the Better Business Bureau, so site visitors do not have to worry about getting scammed. EverQuote, which was accredited in 2011 by the BBB, has a […]
A Rare Opportunity to Turn $1,000 into $461,800
On August 30, 2019, a small firm won a contract from the Pentagon to build a strange new weapon. The Joint Chiefs of Staff calls this new weapon "Unstoppable." This under-the-radar company is not yet a household name.
Our research proves that anyone who gets in now could turn $1,000 into $461,800 >>>
Airbnb Investment Thesis
Airbnb [NASDAQ: ABNB] is the well-known home rental platform that connects hosts who want to rent out their homes with people who are looking for accommodation in that area. The platform is accessible via website and mobile app. Founded in 2008 by Brian Chesky, Joe Gebbia, and Nathan Blecharczyk, Airbnb has grown into a global […]
Is this Killer new EXTRA INCOME strategy the Best Side Hustle EVER?
Have you seen this new extra-income hack yet?
Everyday Americans have been making 100%, 200%, 500%, or more... sometimes in a matter of days with this one new strategy. Some of them are retiring from their jobs because of it. Others have paid off all their debt and bought their dream homes.
You can see their stories for yourself right here.
Best Hotel Stocks to Buy
Best Hotel Stocks To Buy: When you think about stocks that perform well when the economy is up, consumer goods stocks probably come to mind, but they are not the only companies that tend to do well in a bull market. Stocks in other sectors perform well too. One of the chief industries to see […]
Power Your Portfolio With Advanced Forecasting
Go after the same opportunities as the ultra-rich by using market forecasting so you can find the best trades. This breakthrough technology helps you build a more secure financial future because it removes all guesswork.
For a limited time, see a LIVE demonstration of the technology specifically made to help independent traders jump on trends at the most opportune time.
View this email online if it doesn't display correctly. This newsletter is not financial advice. Please read our Disclaimer.
To unsubscribe from Financhill, click here.
PO Box 126
Catasauqua, PA 18032
Financhill is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. Further, owners, employees, agents or representatives of Financhill are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory.
The sender of this email makes no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email, and makes no representations or warranties concerning said company or entity's compliance with applicable laws and regulations, including, but not limited to, regulations promulgated by the SEC or the CFTC. The sender of this email may receive a portion of the proceeds from the sale of any products or services offered by a company or entity mentioned or recommended in this email. The recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability, for any purchase or order made from any company or entity mentioned or recommended in this email.
The content on any of Financhill websites, products or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options and other securities involves risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities is not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors. See: Characteristics and Risks of Standardized Options. The Financhill.com educational training program and software services are provided to improve financial understanding.
The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing.
Past performance is no guarantee of future performance. This product is for educational purposes only. Practical application of the products herein are at your own risk and Financhill.com, its partners, representatives and employees assume no responsibility or liability for any use or mis-use of the product. Please contact your financial advisor for specific financial advice tailored to your personal circumstances. Any trades shown are hypothetical example and do not represent actual trades. Actual results may differ. Nothing here in constitutes a recommendation respecting the particular security illustrated.
No comments:
Post a Comment